Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shilpa Grover, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Haryal A, Townsend MJ, Baskaran V, Srivoleti P, Giobbie-Hurder A, Sack JS, Isidro RA, LeBoeuf NR, Buchbinder EI, Hodi FS, Grover S. Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course. Cancer. 2022 Nov 14. PMID: 36377339.
    Citations:    Fields:    
  2. Tyan K, Abu-Shawer O, Baginska J, Severgnini M, Manos M, Vaitkevicius H, Grover S, Hodi FS, Rahma OE. Multiple high-grade and rare immune-related adverse events in a colon cancer patient with genomic and cytokine profiling. Immunotherapy. 2022 08; 14(11):843-850. PMID: 35695027.
    Citations:    Fields:    Translation:Humans
  3. Li M, Wong D, Vogel AS, Sack JS, Rahma OE, Hodi FS, Zucker SD, Grover S. Effect of corticosteroid dosing on outcomes in high-grade immune checkpoint inhibitor hepatitis. Hepatology. 2022 03; 75(3):531-540. PMID: 34709662.
    Citations: 1     Fields:    Translation:Humans
  4. Li M, Sack JS, Bell P, Rahma OE, Srivastava A, Grover S, Zucker SD. Utility of Liver Biopsy in Diagnosis and Management of High-grade Immune Checkpoint Inhibitor Hepatitis in Patients With Cancer. JAMA Oncol. 2021 11 01; 7(11):1711-1714. PMID: 34554206; PMCID: PMC8461544.
    Citations:    Fields:    Translation:Humans
  5. Atieh J, Sack J, Thomas R, Rahma OE, Camilleri M, Grover S. Correction to: Gastroparesis Following Immune Checkpoint Inhibitor Therapy: A Case Series. Dig Dis Sci. 2021 Aug; 66(8):2843-2844. PMID: 32767043.
    Citations:    Fields:    
  6. Bui AN, Tyan K, Giobbie-Hurder A, Klein IA, Manos MP, Zubiri L, Reynolds K, Grover S, Weinhouse GL, Ott PA, LeBoeuf NR, Rahma O. Impact of COVID-19 on Patients with Cancer Receiving Immune Checkpoint Inhibitors. J Immunother Precis Oncol. 2021 May; 4(2):35-44. PMID: 35663537; PMCID: PMC9153254.
    Citations: 2     
  7. Grover S, Redd WD, Zhou JC, Nije C, Wong D, Hathorn KE, McCarty TR, Bazarbashi AN, Shen L, Chan WW. High Prevalence of Gastrointestinal Manifestations of COVID-19 Infection in Hospitalized Patients With Cancer. J Clin Gastroenterol. 2021 01; 55(1):84-87. PMID: 33116066; PMCID: PMC7718415.
    Citations: 3     Fields:    Translation:Humans
  8. Isidro RA, Ruan AB, Gannarapu S, Raj D, Rahma O, Grover S, Srivastava A. Medication-specific variations in morphological patterns of injury in immune check-point inhibitor-associated colitis. Histopathology. 2021 Mar; 78(4):532-541. PMID: 32931028.
    Citations: 1     Fields:    Translation:Humans
  9. Li M, Sack JS, Rahma OE, Hodi FS, Zucker SD, Grover S. Outcomes after resumption of immune checkpoint inhibitor therapy after high-grade immune-mediated hepatitis. Cancer. 2020 12 01; 126(23):5088-5097. PMID: 32888341; PMCID: PMC7655516.
    Citations: 9     Fields:    Translation:Humans
  10. Grover S, Bond SA, Mansour MK, Friedman S. Management of immunotherapy colitis: Special considerations in the COVID-19 era. Cancer. 2020 11 01; 126(21):4630-4633. PMID: 32797685; PMCID: PMC7461305.
    Citations: 2     Fields:    Translation:Humans
  11. Atieh J, Sack J, Thomas R, Rahma OE, Camilleri M, Grover S. Gastroparesis Following Immune Checkpoint Inhibitor Therapy: A Case Series. Dig Dis Sci. 2021 06; 66(6):1974-1980. PMID: 32594464; PMCID: PMC7867661.
    Citations:    Fields:    Translation:Humans
  12. Ukaegbu C, Levi Z, Fehlmann TD, Uno H, Chittenden A, Inra JA, Grover S, Kastrinos F, Syngal S, Yurgelun MB. Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals. Fam Cancer. 2021 04; 20(2):111-116. PMID: 32743790; PMCID: PMC7854904.
    Citations: 3     Fields:    Translation:Humans
  13. Abu-Shawer O, Singh P, Yenulevich E, Brito A, Ni J, Abdulnour RE, Grover S, Manos M, Bowling P, LeBoeuf NR, Ott P, Stephen Hodi F, Jacobson J, Rahma O. Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) service. J Immunother Cancer. 2020 08; 8(2). PMID: 32817360.
    Citations: 2     Fields:    Translation:Humans
  14. Grover S, Dougan M, Tyan K, Giobbie-Hurder A, Blum SM, Ishizuka J, Qazi T, Elias R, Vora KB, Ruan AB, Martin-Doyle W, Manos M, Eastman L, Davis M, Gargano M, Haq R, Buchbinder EI, Sullivan RJ, Ott PA, Hodi FS, Rahma OE. Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis. Cancer. 2020 08 15; 126(16):3758-3767. PMID: 32567084; PMCID: PMC7381363.
    Citations: 11     Fields:    Translation:HumansCells
  15. Grover S, Ruan AB, Srivoleti P, Giobbie-Hurder A, Braschi-Amirfarzan M, Srivastava A, Buchbinder EI, Ott PA, Kehl KL, Awad MM, Hodi FS, Rahma OE. Safety of Immune Checkpoint Inhibitors in Patients With Pre-Existing Inflammatory Bowel Disease and Microscopic Colitis. JCO Oncol Pract. 2020 09; 16(9):e933-e942. PMID: 32401685.
    Citations: 8     Fields:    Translation:Humans
  16. Johncilla M, Grover S, Zhang X, Jain D, Srivastava A. Morphological spectrum of immune check-point inhibitor therapy-associated gastritis. Histopathology. 2020 Mar; 76(4):531-539. PMID: 31692018.
    Citations: 18     Fields:    Translation:Humans
  17. Grover S, Srivastava A. Lymphocytic colitis-like pattern of mucosal injury and the challenges in diagnosing cancer immunotherapy-related toxicity. Cancer. 2019 06 01; 125(11):1768-1770. PMID: 30892689.
    Citations: 1     Fields:    Translation:Humans
  18. Grover S, Rahma OE, Hashemi N, Lim RM. Gastrointestinal and Hepatic Toxicities of Checkpoint Inhibitors: Algorithms for Management. Am Soc Clin Oncol Educ Book. 2018 May 23; 38:13-19. PMID: 30231401.
    Citations: 16     Fields:    Translation:Humans
  19. Grover S, Lim RM, Blumberg RS, Syngal S. Oncogastroenterology. J Clin Oncol. 2016 Apr 01; 34(10):1154-5. PMID: 26834060.
    Citations: 2     Fields:    Translation:Humans
  20. Grover S, Jajoo K. Screening for Pancreatic Cancer in High-risk Populations. Gastroenterol Clin North Am. 2016 Mar; 45(1):117-27. PMID: 26895684.
    Citations: 1     Fields:    Translation:Humans
  21. Inra JA, Steyerberg EW, Grover S, McFarland A, Syngal S, Kastrinos F. Racial variation in frequency and phenotypes of APC and MUTYH mutations in 6,169 individuals undergoing genetic testing. Genet Med. 2015 Oct; 17(10):815-21. PMID: 25590978; PMCID: PMC4904772.
    Citations: 7     Fields:    Translation:Humans
  22. Grover S, Kastrinos F, Steyerberg EW, Cook EF, Dewanwala A, Burbidge LA, Wenstrup RJ, Syngal S. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA. 2012 Aug 01; 308(5):485-492. PMID: 22851115; PMCID: PMC3770297.
    Citations: 53     Fields:    Translation:Humans
  23. Grover S, Ashley SW, Raut CP. Small intestine gastrointestinal stromal tumors. Curr Opin Gastroenterol. 2012 Mar; 28(2):113-23. PMID: 22157511.
    Citations: 13     Fields:    Translation:Humans
  24. Grover S, Currier PF, Elinoff JM, Katz JT, McMahon GT. Improving residents' knowledge of arterial and central line placement with a web-based curriculum. J Grad Med Educ. 2010 Dec; 2(4):548-54. PMID: 22132276.
    Citations: 2     Fields:    
  25. Grover S, Syngal S. Hereditary pancreatic cancer. Gastroenterology. 2010 Oct; 139(4):1076-80, 1080.e1-2. PMID: 20727885; PMCID: PMC3149791.
    Citations: 40     Fields:    Translation:Humans
  26. Stoffel EM, Mercado RC, Kohlmann W, Ford B, Grover S, Conrad P, Blanco A, Shannon KM, Powell M, Chung DC, Terdiman J, Gruber SB, Syngal S. Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Am J Gastroenterol. 2010 Aug; 105(8):1851-60. PMID: 20354509.
    Citations: 36     Fields:    Translation:HumansPHPublic Health
  27. Grover S, Syngal S. Risk assessment, genetic testing, and management of Lynch syndrome. J Natl Compr Canc Netw. 2010 Jan; 8(1):98-105. PMID: 20064292.
    Citations: 9     Fields:    Translation:Humans
  28. Grover S, Currier PF, Elinoff JM, Mouchantaf KJ, Katz JT, McMahon GT. Development of a test to evaluate residents' knowledge of medical procedures. J Hosp Med. 2009 Sep; 4(7):430-2. PMID: 19753571.
    Citations: 3     Fields:    Translation:Humans
  29. Grover S, Stoffel EM, Mercado RC, Ford BM, Kohlman WK, Shannon KM, Conrad PG, Blanco AM, Terdiman JP, Gruber SB, Chung DC, Syngal S. Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome. J Clin Oncol. 2009 Aug 20; 27(24):3981-6. PMID: 19620492.
    Citations: 13     Fields:    Translation:HumansCells
  30. Grover S, Syngal S. Genetic testing in gastroenterology: Lynch syndrome. Best Pract Res Clin Gastroenterol. 2009; 23(2):185-96. PMID: 19414145.
    Citations: 8     Fields:    Translation:Humans
  31. Grover S, Hamilton MJ, Carr-Locke DL. Refractory Clostridium difficile-associated diarrhea. MedGenMed. 2007 May 29; 9(2):46. PMID: 17955101.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  32. Wang V, Dorfman DM, Grover S, Carr-Locke DL. Enterocolic fistula associated with an intestinal lymphoma. MedGenMed. 2007 Feb 07; 9(1):28. PMID: 17435634.
    Citations: 3     Fields:    Translation:Humans
  33. Grover S, Stoffel EM, Bussone L, Tschoegl E, Syngal S. Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol. 2004 Sep; 2(9):813-9. PMID: 15354282.
    Citations: 55     Fields:    Translation:Humans
  34. Stoffel EM, Garber JE, Grover S, Russo L, Johnson J, Syngal S. Cancer surveillance is often inadequate in people at high risk for colorectal cancer. J Med Genet. 2003 May; 40(5):e54. PMID: 12746408; PMCID: PMC1735467.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  35. Shilpa Grover, Blueprints Gastroenterology, Lippincott Williams & Wilkins. May, 2007.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Grover's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (152)
Co-Authors (43)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.